Company Information
USD
27.05
- (0.07%)
NASDAQ:COLL, COLLEGIUM PHARMACEUTICAL, INC.
Industry: Drug Manufacturers - Specialty & Generic
End of Day: 7 May 2025 GMT-4
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
Address
100 Technology Center Drive
Classification
Sector
Healthcare
Industry Group
Drug Manufacturers
Industry
Drug Manufacturers - Specialty & Generic
Key Executives
Mr. Gino Santini
Director
Dr. John G. Freund,M.D.
Director
Mr. Garen G. Bohlin
Director
Mr. Michael T. Heffernan, R.Ph.
Chairman of the Board/Director/Founder
Ms. Gwen A. Melincoff
Director
Dr. John A. Fallon, M.D.
Director
Mr. Neil F. McFarlane
Director
Mr. Joseph J. Ciaffoni
CEO/Director/President
Ms. Shirley R. Kuhlmann
Chief Administrative Officer/Executive VP/General Counsel/Secretary
Mr. Scott Dreyer
Executive VP/Other Executive Officer
Dr. Thomas B. Smith, M.D.
Chief Medical Officer/Executive VP
Dr. Rita Balice-Gordon, PhD
Director
Ms. Colleen Tupper
CFO/Chief Accounting Officer/Executive VP
Ownership
Institution Holdings
BlackRock Inc
5,786,993 (18.107%)
BlackRock Fund Advisors
3,982,896 (12.462%)
Rubric Capital Management LP
2,758,253 (8.630%)
Eventide Asset Management, LLC
2,630,478 (8.231%)
Vanguard Group Inc
2,312,786 (7.237%)
Pacer Advisors, INC.
2,174,718 (6.805%)
Principal Financial Group Inc
1,569,151 (4.910%)
Amvescap Plc.
1,441,617 (4.511%)
Renaissance Technologies Corp
1,384,598 (4.332%)
State Street Corporation
1,313,875 (4.111%)
Individual Holdings
Ms. Shirley R. Kuhlmann
164,409 (0.514%)
Ms. Colleen Tupper
150,555 (0.471%)
Mr. Scott Dreyer
138,918 (0.435%)
Dr. Thomas B. Smith, M.D.
63,409 (0.198%)
Mr. Gino Santini
67,963 (0.197%)
Dr. John A. Fallon, M.D.
47,150 (0.136%)
Dr. John G. Freund,M.D.
44,775 (0.129%)
Mr. Garen G. Bohlin
44,775 (0.129%)
Ms. Gwen A. Melincoff
44,775 (0.129%)
Mr. Neil F. McFarlane
41,672 (0.121%)
Funds Holdings
Pacer US Small Cap Cash Cows 100 ETF
2,894,122 (9.056%)
iShares Core S&P Small-Cap ETF
2,222,173 (6.953%)
iShares Russell 2000 ETF
831,297 (2.601%)
Vanguard Institutional Extnd Mkt Idx Tr
470,225 (1.471%)
Invesco Small Cap Core
457,039 (1.430%)
Principal SmallCap Fund
356,900 (1.117%)
Fidelity Small Cap Index Fund
343,751 (1.076%)
Victory Integrity Small-Cap Value Fund
340,000 (1.064%)
Integrity Small-Cap Value Comp
340,000 (1.064%)
PGI U.S. Small Cap Equity
335,300 (1.049%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
